Sreeja Biswas

Premium

General

23 September, 2024

Grapevine: Nexus Select in talks to acquire mall; Anand Rathi, PhysicsWallah eye IPOs

Nexus Select Trust, backed by Blackstone, is in discussions to acquire Axis Mall in Kolkata, a media report said.   However, ......

Premium

Finance

20 September, 2024

Blume-backed Optimo Loan may tap new international investor in fresh fundraise

Small business-focused lending startup Optimo Loan, which was launched by Easemytrip’s co-founder Prashant Pitti and is backed by venture capital ......

Healthcare

20 September, 2024

Advent-controlled Suven Pharma appoints former Piramal exec as chairman

Private equity firm Advent International-controlled Suven Pharmaceuticals Ltd has appointed former Piramal Pharma Solutions Ltd’s chief executive officer Vivek Sharma ......

Premium

General

20 September, 2024

Grapevine: Adani eyes another cement maker; SP Group firm raising funding

Adani Group is close to acquiring a 46.64% stake in ITD Cementation India for Rs 5,889 crore ($700 million), including ......

Premium

Manufacturing

19 September, 2024

Cipla Health weighs controlling stake in PE-backed nutrition brand

Cipla Health Ltd, the wholly-owned subsidiary and consumer healthcare arm of Cipla, is evaluating  a majority stake purchase in a ......

Premium

General

19 September, 2024

Grapevine: Temasek eyes hospital chain; Thyrocare weighs radiology ops divestment

Temasek Holdings is nearing a deal to acquire Peak XV's 18-20% stake in Bengaluru-based Cloudnine Hospitals for around $125 million (Rs 1,046 crore), a ......

Premium

General

18 September, 2024

Grapevine: Aragen Life, Urban Company investors weigh stake sale

Promoters and investors in Aragen Life Sciences, the Goldman Sachs-backed contract research organisation (CRO), plan to sell a 10% stake in a ......

Premium

Healthcare

17 September, 2024

PE firms mull buying stake in Apex Hospitals as existing backer seeks exit

Rajasthan-based Apex Hospitals Pvt. Ltd is being evaluated by multiple private equity players for a potential stake buy, as current ......

Healthcare

17 September, 2024

Zydus Life acquires Sterling Biotech's API formulation business

Listed pharma player Zydus Lifesciences, erstwhile Cadila Healthcare, has announced the acquisition of Sterling Biotech’s active pharmaceutical ingredients business for ......

Premium

Healthcare

17 September, 2024

VC-backed Redcliffe onboards new investor in Series C funding

Redcliffe Lifetech Pvt Ltd, which operates diagnostic centers under the Redcliffe Labs brand, has raised Series C funding from existing backers ......